Considering the well-known fact that a background liver functional reservoir is the important determinant of prognosis of u-HCC patients treated with pharmacotherapy [37], the presence of a TERT mutation may reflect more advanced background liver disease and be associated with shorter OS. Here, TERT is linked to hepatocellular carcinoma.